Lymphoid enhancer binding factor 1 (LEF1), a key mediator of Wnt signaling, has been linked to leukemic transformation, and LEF1 mutations have been identified in T-ALL. This evidence concerns the gene LEF1 and acute lymphoblastic leukemia.